NASDAQ:APLS
Apellis Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.apellis.comipo date
Nov 09, 2017
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atro...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus